GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aurobindo Pharma Ltd

Aurobindo Pharma: GST appellate order upholds Rs 77.61 Cr demand, interest waived

ORDERS ● No Immediate Change MEDIUM RISK
📅 Filed on BSE: 13 Mar 2026, 12:50 PM IST  ·  BSE ID: 18dd2fd4-c2de-4368-9347-3747f6bc3faa
View Original BSE Filing (PDF)
🤖 AI Summary
  • The Principal Commissioner of Customs and Central Tax (Appeals I), Hyderabad, has confirmed a GST demand against Aurobindo Pharma for Rs 77,61,35,242/- with an equal penalty of Rs 77,61,35,242/-. The violations relate to excess IGST refunds on exports (CIF vs FOB), non-surrender of IGST on short export realization, and non-reversal of input tax credits during July 2017 to March 2020. The appellate authority partly allowed the company's appeal by waiving interest on ITC reversals but upheld the demand and penalty. The company has already paid Rs 23,71,71,782/- under protest and reversed Rs 8,78,23,385/- in ITC, both accepted by authorities. Management states no material financial impact and plans to appeal to the GST Appellate Tribunal within stipulated time.
🔢 Key Numbers — exact figures from BSE filing, not rounded
GST Demand
Rs 77,61,35,242
Penalty Amount
Rs 77,61,35,242
Amount Already Paid Under Protest
Rs 23,71,71,782
ITC Reversed and Accepted
Rs 8,78,23,385
Export Period Covered
01.07.2017 to 23.03.2020
Order Receipt Date
March 12, 2026
👥 What This Means For Shareholders
✅
Action Required
No action required. Monitor GSTAT appeal outcome announcement; disclosure will trigger stock exchange filing once tribunal decision received.
👤
Who Is Affected
All shareholders potentially affected by balance sheet contingent liability valuation. Material adverse ruling could impact retained earnings and credit covenants, affecting dividend capacity and financial flexibility.
🔍
Management Signal
Company contesting demand through appellate channels rather than settling, signaling confidence in legal position and export transaction legitimacy. No admission of violation implied.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
GSTAT appeal filing confirmation and tribunal hearing date announcement
Half-yearly balance sheet: contingent liability disclosure changes or settlement updates
Final judgment from Goods and Services Tax Appellate Tribunal on appeal
MEDIUM RISK Rs 155.23 Cr combined demand remains contingent liability. Adverse GSTAT ruling could materially impact cash and credit position. Export compliance violations signal regulatory risk persistence.
💡 Investor Takeaway
Aurobindo faces Rs 155.23 Cr GST demand covering exports from July 2017-March 2020. Appellate authority waived interest but upheld demand and penalty. Company plans GSTAT appeal. No material financial impact claimed, but contingent liability remains unresolved until tribunal judgment.
⚖️ Strengths & Concerns

✅ Positives

  • Appellate authority waived interest on ITC reversal demand, reducing total exposure burden beyond principal and penalty.
  • Company already paid Rs 23.72 Cr under protest; Rs 8.78 Cr ITC reversal accepted, limiting further contingent liability.

⚠️ Concerns

  • Combined GST demand and penalty of Rs 155.23 Cr remains outstanding; confirms export-related compliance violations across three-year period.
  • Appellate authority upheld original demand and penalty despite company challenge, limiting legal options before GSTAT appeal.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.